Related references
Note: Only part of the references are listed.CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC).
Alan P. Venook et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
HIPEC: standard of care or an experimental approach?
Serge Evrard et al.
LANCET ONCOLOGY (2012)
Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach?
Paul H. Sugarbaker et al.
LANCET ONCOLOGY (2012)
Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion Versus Systemic Chemotherapy Alone for Colorectal Peritoneal Carcinomatosis
Jan Franko et al.
CANCER (2010)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer: A Panacea or Just an Obstacle Course for the Patient?
Vijay P. Khatri
JOURNAL OF CLINICAL ONCOLOGY (2010)
Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French Study
Dominique Elias et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy
Tristan D. Yan et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2010)
Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure? A Systematic Review of Morbidity and Mortality
Terence C. Chua et al.
ANNALS OF SURGERY (2009)
The Second Procedure Combining Complete Cytoreductive Surgery and Intraperitoneal Chemotherapy for Isolated Peritoneal Recurrence: Postoperative Course and Long-Term Outcome
Antoine Brouquet et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection
T. C. Chua et al.
EJSO (2009)
Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin
Dominique Elias et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
8-year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer
Vic J. Verwaal et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination
Jesus Esquivel et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
Multimodality treatment of peritoneal carcinomatosis from colorectal cancer: first results of a new German centre for peritoneal surface malignancies
P. Piso et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2007)
Failure analysis of recurrent disease following complete cytoreduction and Perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer
Lana Bijelic et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver Metastases
Reza Kianmanesh et al.
ANNALS OF SURGERY (2007)
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: A consensus statement
J. Esquivel et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Peritoneal carcinomatosis of colorectal origin: Standard of care
Tristan D. Yan
ANNALS OF SURGERY (2006)
Phase II studies: International registry of colorectal carcinomatosis
F. N. Gilly
EJSO (2006)
Treatment of peritoneal carcinomatosis from colorectal cancer: Impact of complete cytoreductive surgery and difficulties in conducting randomized trials
D Elias et al.
ANNALS OF SURGICAL ONCOLOGY (2004)
Improved survival in patients with peritoneal metastases from colorectal cancer:: a preliminary study
H Mahteme et al.
BRITISH JOURNAL OF CANCER (2004)
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study
O Glehen et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
D Dindo et al.
ANNALS OF SURGERY (2004)
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer
VJ Verwaal et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Peritoneal carcinomatosis from colorectal cancer
DG Jayne et al.
BRITISH JOURNAL OF SURGERY (2002)
Share Paper
